RééDOC
75 Boulevard Lobau
54042 NANCY cedex

Christelle Grandidier Documentaliste
03 83 52 67 64


F Nous contacter

0

Article

--";3! O
     

-A +A

Validity and clinimetric properties of the Spinal Alignment and Range of Motion Measure in children with cerebral palsy

CHEN CL; WU KP; LIU WY; CHENG HY; SHEN IH; LIN KC
DEV MED CHILD NEUROL , 2013, vol. 55, n° 8, p. 745-750
Doc n°: 165070
Localisation : Documentation IRR

D.O.I. : http://dx.doi.org/DOI:10.1111/dmcn.12153
Descripteurs : AJ23 - PARALYSIE CEREBRALE

The aim of this study was to assess the validity, responsiveness, and
clinimetric properties of the Spinal Alignment and Range of Motion Measure
(SAROMM) in children with cerebral palsy (CP). METHOD: Sixty-two children with CP
(40 males, 22 females) with a median age of 3 years and 11 months (range 1-6y)
and their caregivers participated in this study. Among the children, 56 had
spastic CP while six had non-spastic CP; 53 had bilateral CP, while nine had
unilateral limb involvement. Thirty-three children were classified as Gross Motor
Function Classification System (GMFCS) levels I to III and 23 as levels IV or V.
Fifty-six children (90%) received regular rehabilitation by means of regular
physical or occupational therapy (50% once or twice per week and 40% more than
two times per week) and six children (10%) received irregular rehabilitation
(less than once a week). Construct validity was determined by assessing the
strength of the correlation between the spinal alignment SAROMM (SAROMM-SA), the
range of motion SAROMM (SAROMM-ROM), and the total SAROMM (SAROMM-total), and
construct measures, including the 66-item Gross Motor Function Measure (GMFM-66)
and Functional Independence Measures for Children (WeeFIM), at baseline and at
6-months follow-up. Responsiveness was examined using effect size. Minimal
detectable change (MDC) at the 90% confidence level (MDC90) and minimal
clinically important difference (MCID) were analysed. RESULTS: The SAROMM with
the GMFM-66 and WeeFIM had fair to good construct validity. The effect size
values of all SAROMM scales were 0.24 to 0.48. The MDC90 values and MCID range
were 1.43 and 0.47 to 1.67 for the SAROMM-SA, 3.12 and 3.68 to 4.07 for the
SAROMM-ROM, and 3.22 and 4.53 to 4.62 for the SAROMM-total. INTERPRETATION: The
clinimetric properties of the SAROMM allow clinicians to determine whether a
change in SAROMM score represents a clinically meaningful change.
CI - (c) 2013 Mac Keith Press.

Langue : ANGLAIS

Mes paniers

4

Gerer mes paniers

0